Bausch + Lomb (BLCO)

Bausch & Lomb Argentina S.R.L. • Waicon Vision S.A. • AcuFocus Australia • Bausch & Lomb (Australia) Pty Ltd • Bausch & Lomb Australia Holdings Pty Ltd. • BAUSCH HEALTH LLC • Bausch & Lomb Pharma S.A. • BL Indústria Ótica Ltda. • Beijing Bausch & Lomb Eyecare Company Ltd • Shandong Bausch & Lomb Freda New Packaging Materials Co., Ltd. ...

BLCO stock data

1M 1Y 5Y

Analyst ratings and price targets

Last 3 months

Average target

$19.50

Low target

$17.00

High target

$21.00

Latest filings (excl ownership)

View all

ARS

2022 FY

Annual report to shareholders

13 Mar 23

DEFA14A

Additional proxy soliciting materials

Bausch + Lomb Announces Fourth-Quarter and Full-Year 2022 Results

22 Feb 23

8-K

Departure of Directors or Certain Officers

15 Feb 23

8-K

Bausch + Lomb Amends CEO Separation Agreement

2 Nov 22

Bausch + Lomb Announces Third-Quarter 2022 Results

4 Aug 22

Transcripts

BLCO

Earnings call transcript

2022 Q4

22 Feb 23

BLCO

Earnings call transcript

2022 Q3

2 Nov 22

BLCO

Earnings call transcript

2022 Q2

7 Aug 22

BLCO

Earnings call transcript

2022 Q1

8 Jun 22

Latest ownership filings

View all

Bausch Health Companies Inc.

Financial summary

Financial statements Chart BLCO financial data

Quarter (USD)	Dec 22	Sep 22	Jun 22	Mar 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q4 2022

BLCO institutional ownership history Ownership history

13F holders	Current	Change
Total holders	88	NEW
Opened positions	88	NEW
Closed positions	0
Increased positions	0
Reduced positions	0

13F shares	Current	Prev Q	Change
Total value	681.62 bn	0.00	NEW
Total shares	355.11 mm	0.00	NEW
Total puts	4.80 k	0.00	NEW
Total calls	49.20 k	0.00	NEW
Total put/call ratio	0.1	–	–

Largest owners	Shares	Value	Change
BHC Bausch Health Companies	310.45 mm	$0.00	NEW
Goldentree Asset Management	6.33 mm	$98.15 bn	NEW
Eminence Capital	4.21 mm	$65.25 bn	NEW
BLK Blackrock	4.15 mm	$64.39 bn	NEW
FIL	3.62 mm	$56.21 bn	NEW
Icahn Carl C Et Al	3.50 mm	$54.29 bn	NEW
Norges Bank	2.80 mm	$43.43 bn	NEW
Maple Rock Capital Partners	2.49 mm	$38.64 bn	NEW
River Road Asset Management	1.65 mm	$25.63 bn	NEW
Southpoint Capital Advisors	1.50 mm	$23.27 bn	NEW

Largest transactions	Shares	Bought/sold	Change
BHC Bausch Health Companies	310.45 mm	+310.45 mm	NEW
Goldentree Asset Management	6.33 mm	+6.33 mm	NEW
Eminence Capital	4.21 mm	+4.21 mm	NEW
BLK Blackrock	4.15 mm	+4.15 mm	NEW
FIL	3.62 mm	+3.62 mm	NEW
Icahn Carl C Et Al	3.50 mm	+3.50 mm	NEW
Norges Bank	2.80 mm	+2.80 mm	NEW
Maple Rock Capital Partners	2.49 mm	+2.49 mm	NEW
River Road Asset Management	1.65 mm	+1.65 mm	NEW
Southpoint Capital Advisors	1.50 mm	+1.50 mm	NEW

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

BLCO insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
1 Mar 23	Christina Ackermann	Common Shares, No Par Value	Grant	Acquire A	No	No	0	28,344	0.00	146,677
1 Mar 23	Christina Ackermann	NQSO Common Shares, No Par Value	Grant	Acquire A	No	No	17.96	90,744	1.63 mm	90,744
1 Mar 23	Sam Eldessouky	Common Shares, No Par Value	Grant	Acquire A	No	No	0	42,517	0.00	202,517
1 Mar 23	Sam Eldessouky	NQSO Common Shares, No Par Value	Grant	Acquire A	No	No	17.96	136,116	2.44 mm	136,116
1 Mar 23	Joseph F Gordon	Common Shares, No Par Value	Grant	Acquire A	No	No	0	21,258	0.00	125,702
1 Mar 23	Joseph F Gordon	NQSO Common Shares, No Par Value	Grant	Acquire A	No	No	17.96	68,058	1.22 mm	68,058